US ONCOLOGY HOLDINGS, INC. $425,000,000 Senior Unsecured Floating Rate Toggle Notes Due 2012 Registration Rights AgreementUs Oncology Inc • March 16th, 2007 • Services-specialty outpatient facilities, nec • New York
US Oncology Holdings, Inc., a corporation organized under the laws of Delaware (the “Issuer”), which is the parent of US Oncology, Inc., a corporation organized under the laws of Delaware, proposes to issue and sell to certain purchasers (the “Initial Purchasers”), for whom you (the “Representatives”) are acting as representatives, $425,000,000 principal amount of its Senior Unsecured Floating Rate Toggle Notes Due 2012 (the “Securities”), upon the terms set forth in the Purchase Agreement between the Issuer and the Representatives, dated March 1, 2007 (the “Purchase Agreement”), relating to the initial placement (the “Initial Placement”) of the Securities. To induce the Initial Purchasers to enter into the Purchase Agreement and to satisfy a condition to your obligations thereunder, the Issuer agrees with you for your benefit and the benefit of the holders from time to time of the Securities (including the Initial Purchasers) (each a “Holder” and, collectively, the “Holders”), as foll
US ONCOLOGY HOLDINGS, INC. $425,000,000 Senior Unsecured Floating Rate Toggle Notes Due 2012 Purchase AgreementUs Oncology Inc • March 16th, 2007 • Services-specialty outpatient facilities, nec • New York
US Oncology Holdings, Inc., a corporation organized under the laws of Delaware (the “Issuer”), which is the parent of US Oncology, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to issue and sell to the several parties named in Schedule I hereto (the “Initial Purchasers”), for whom you (the “Representatives”) are acting as representatives, $425,000,000 principal amount of its Senior Unsecured Floating Rate Toggle Notes Due 2012 (the “Securities”). The Securities are to be issued under an indenture (the “Indenture”), to be dated as of March 13, 2007, between the Issuer and LaSalle Bank National Association, as trustee (the “Trustee”). The Securities have the benefit of a Registration Rights Agreement (the “Registration Rights Agreement”), dated as of the date hereof, between the Issuer and the Initial Purchasers, pursuant to which the Issuer has agreed to register the Securities under the Act subject to the terms and conditions therein specified. To t
ContractUs Oncology Inc • March 16th, 2007 • Services-specialty outpatient facilities, nec • New York
AMENDMENT NO. 5 dated as of March 1, 2007 (this “Amendment”), among US ONCOLOGY HOLDINGS, INC. (“Holdings”), US ONCOLOGY, INC. (the “Borrower”), the Subsidiary Loan Parties (as defined in the Credit Agreement (as defined below)) the LENDERS party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent.
